Andere Sprachen Core One Labs Inc.

Aktien

A3CSSU

CA21872J3073

COOL

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 15:30:04 10.06.2024			% 5 Tage	% 1. Jan.
0,17 ^CAD	-5,56 %		-5,56 %	-41,38 %

29.02.	Core One Labs Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023	CI
2023	Core One Labs Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Core One Labs : Announces Extension of Non-Brokered Private Placement	16.05.
Core One Labs : Announces Non-Brokered Private Placement	09.04.
Core One Labs Inc. announced that it expects to receive CAD 1.5 million in funding	09.04.
Core One Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	29.02.
Core One Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	03.11.
Core One Labs Inc. announced that it has received CAD 0.2 million in funding	18.09.23
Core One Labs : Announces Non-Brokered Private Placement	11.09.23
Core One Labs Inc. announced that it expects to receive CAD 1 million in funding	11.09.23
Core One Labs Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	29.08.23
Core One Labs : Commends Study Exploring Psychedelics’ Efficacy in Providing Relief for Chronic Pain Conditions	24.08.23
Core One's Akome Reveals Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer?s and Parkinson's Disease	05.08.23
Core One Labs : Applauds Groundbreaking Research on Psilocybin as a Potential Anorexia Treatment	04.08.23
Core One Labs Inc. Reports Earnings Results for the Fifteen Months Ended March 31, 2023	03.08.23
Core One Labs Inc.'s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer?s and Parkinson?s Disease	29.07.23
Core One Labs : Applauds California Assembly Health Committee’s Approval of Bill to Legalize Psychedelics	19.07.23
Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process	12.07.23
Core One's Vocan Files International Patent For Breakthrough Proprietary Biosynthetic Psilocybin Production Method	10.07.23
Core One Labs Inc. Applauds FDA's Draft Guidance on Clinical Trials for Psychedelic Drugs	27.06.23
Core One Labs : Applauds FDA’s Draft Guidance on Clinical Trials for Psychedelic Drugs	27.06.23
Core One Labs Says in Talks with Multiple Companies to Supply Psilocybin; COOL Gained 15% on Friday	08.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Core One Labs Inc.

Aktien

A3CSSU

CA21872J3073

COOL

Andere Sprachen

Filter